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Abstract
Purpose—This study examined whether race/ethnicity had differential effects on breast cancer
care and survival across age strata and cohorts within stages of disease.
Methods—The Detroit Cancer Registry provided 25,997 breast cancer cases. African American
and non-Hispanic white, older Medicare-eligible and younger non-eligible women were compared.
Successive historical cohorts (1975–1980 and 1990–1995) were, respectively, followed until 1986
and 2001.
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Results—African American disadvantages on survival and treatments increased significantly,
particularly among younger women who were much more likely to be uninsured. Within node
positive disease all treatment disadvantages among younger African American women
disappeared with socioeconomic adjustment.
Conclusions—Growth of this racial divide implicates social, rather than biological, forces. Its
elimination will require high quality health care for all.
Keywords
Survival; Health insurance; Socioeconomic factors; Race; Ethnicity; Cancer treatment
Introduction
Racial differences on breast cancer care and survival, sentinel indicators of health care
performance, have been consistently observed in the United States. African American
women have been found to be particularly disadvantaged relative to non-Hispanic white
women [1–6]. Contributing the largest African American sample to the nation’s cancer
Surveillance, Epidemiology and End Results (SEER) program [7], the Detroit metropolitan
area remains an example of extreme racial segregation [8,9]. Consequently, it serves as an
important place to accomplish research on race, health and health care.
Biological and sociological theories have been advanced to explain racial group cancer
survival differences. Racial differences on such tumor characteristics as hormone receptors
have implicated gene-based causal pathways [10,11], but their ability to account for racial
group survival differences has ranged widely [12–16]. As managed care proliferated and the
prevalence of uninsured Americans increased over the past 25 years [17–24], a health
insurance theory has been advanced to explain social, including racial, cancer survival
gradients [25–28]. Various uninsured and underinsured statuses have been found to be
strongly associated with later cancer diagnoses, lack of access to treatments, and ultimately,
to poorer survival [29–33]. African Americans remain significantly disadvantaged on
various indices of socioeconomic status including health insurance coverage [34,35], yet
when they are treated in the same health care systems as their white counterparts, their
cancer survival rates are similar [1,36–41]. These social forces have accounted for much, but
not all of such health outcome differences by race/ethnicity.
The relative weight of these theoretical perspectives may be examined with a historical
analysis. Breast cancer care advances have been a hallmark of the past generation, but have
they been equitably enjoyed by all? It has been suggested that African American women,
particularly those not yet Medicare-eligible, have not [42–46]. These studies suggested a 3-
way interaction (race/ethnicity effect moderated by Medicare eligibility and cohort) in the
prediction of breast cancer survival. This study tested the specific hypothesis that the
widened racial divide was most pronounced among younger African American women.
Clinical wisdom suggests that because greater clinical and managerial discretion attends
lymph node involvement, related treatment inequities were most pronounced for node
positive breast cancer. This study explored a series of 3-way interactions in the prediction of
breast cancer treatment: surgery, radiation therapy, chemotherapy and hormone therapy.
Methods
Five-year survival was calculated for 4,523 African American and 21,474 non-Hispanic
white women with primary invasive breast cancer in the Metropolitan Detroit Cancer
Surveillance System [4–6]. Successive 1975–1980 and 1990–1995 cohorts were followed
until 1986 and 2001, respectively. Putting the focus on overall population health trends,
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logistic regression models tested interactions and estimated associations of race/ethnicity
with all-cause survival and treatments across age strata (less than 65 vs. 65 years of age and
older) and cohorts within stages of disease [47]. The older age categorization is synonymous
with Medicare eligibility, nearly all of whom (99%) are covered for medically necessary
care. The younger age group is 15–20-times as likely to have no such health insurance
coverage [48]. Therefore, younger-older strata are good proxies for being more or less
prevalently underinsured.
Results
In the 1990s, non-Hispanic white women with breast cancer were much more likely than
African American women to have survived 5 years; odds ratio (OR) = 1.94 (95% confidence
interval [CI] 1.79, 2.16). That racial divide had increased significantly since the 1970s (OR
= 1.64, 95% CI 1.46, 1.84). The race by age by cohort interaction on 5-year breast cancer
survival is also depicted in Table 1. As hypothesized, the increased racial disparity
specifically pertained to younger women not yet Medicare-eligible; 1970s OR = 1.60 (1.39,
1.84) vs. 1990s OR = 2.06 (1.85, 2.30). Survival among older, Medicare-eligible, women
was by no means equitable, but the racial divide had not increased significantly among
them; 1970s OR = 1.74 (1.41, 2.16) vs. 1990s OR = 1.79 (1.58, 2.04). This pattern was
apparent for non-metastasized breast cancer with larger disadvantages among younger
African American women with node positive disease.
As for interaction hypothesis explorations on breast cancer care, access disadvantages
increased significantly over time for radiation therapy, chemotherapy and hormone therapy
among younger African American women with node positive disease (Table 2, left side); for
example, chemotherapy 1970s OR = 1.05 (0.87, 1.27) vs. 1990s OR = 1.19 (1.04, 1.36).
However, all three interactions with their attendant African American disadvantages among
younger women were no longer significant after socioeconomic adjustment. The racial
divide that had existed for surgical treatment of node negative breast cancer appears to have
been bridged somewhat among all women with breast cancer, but more so among older
women.
Discussion
African American women with breast cancer have not fully benefited from contemporary
treatment and survival advances. They appear to be more disadvantaged today than they
were a generation ago. Such racial/ethnic disadvantage was particularly pronounced among
younger women who were much more likely to be inadequately insured. These findings are
consistent with well established socioeconomic-dependent associations of being uninsured
with lack of access to best treatments and with consequent poorer survival [29,53–61]. In
fact, notwithstanding the often great indirect costs of cancer, direct cancer care costs have
far outfaced costs of living and of treating most other health conditions [62]. So even many
insured cancer patients may, in fact, be inadequately insured.
Study limitations and strengths
This study could conceivably be limited by its focus on all-cause, rather than cancer-specific
survival. For the following reasons we think it not. Cancer is the underlying cause of most
deaths among younger women with breast cancer [26,27]. Moreover, the underlying cause
of many “non-cancer” deaths can often be directly associated with non-treatment or even
with some cancer treatment complications [63]. And this study’s hypothesized African
American disadvantage among younger women was not only observed for survival, but also
for receipt of a number of treatments. This study could also be limited by the known
incompletion of its chemo and hormonal therapy data: 8% and 4%, respectively [64]. Again,
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we think its pattern of findings not to be potently confounded. Between-race differences on
such incompletion rates were miniscule (typically less than 1%). Missing data status was not
significantly associated with both hypothesized independent (race/ethnicity) and dependent
variables (survival) in any of its within-cohort regression models, so it could not have
confounded them. And a consistent pattern of findings was observed across, not only chemo
and hormonal therapy, but radiation therapy as well.
Conclusions
Race still matters in American health care. The clinical importance of biological differences
notwithstanding, they probably cannot explain the observed increased racial disparities in
breast cancer treatment and survival. It seems farfetched to think that any between-race
oncogenetic differences have systematically changed over this study’s mere generational
time-frame. Contemporary social policies affecting health care access and management
clearly have systematically changed though.
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